BENGALURU (Reuters) – Indian drugmaker Cipla Ltd will price its generic version of Gilead Sciences Inc’s antiviral drug remdesivir for use in COVID-19 patients at less than 5,000 rupees ($66), the company said. FILE PHOTO: Employees and security staff …
See Original Article

Fitch Ratings – Milan – 23 Jun 2020: Fitch Ratings has assigned Centurion Bidco S.p.A. a first-time expected Long-Term Issuer Default Rating (IDR) of ‘B+(EXP)’ with a Stable Outlook. Additionally Fitch has assigned the senior secured notes (SSN) issued by …
See Original Article

… to miss that opportunity just because the capital is not in place at that point in time,” Mistry said Tuesday in an interview with Bloomberg Television.
See Original Article

Braun resigned Friday after the German payment service provider said auditors couldn’t find 1.9 billion euros of cash on its balance sheet. He is accused of having inflated Wirecard’s balance sheet through “feigned income” from transactions with third parties.
See Original Article

British shoppers are continuing to turn to local shops and online grocers amid concerns about visiting supermarkets during the coronavirus pandemic. One in five British households bought groceries online in the past month, pumping up sales for home …
See Original Article